Physician

Achilles Kalnoky, M.D.

According to 2025 Medicare claims, Achilles Kalnoky, M.D. (NPI: 1245460690) practices family practice in the North Port-Bradenton-Sarasota, FL market, with the plurality of this provider's patient population coming from Sarasota, FL. This provider's primary affiliated billing organization is HEALTH FIRST PRIVIA MEDICAL GROUP (NPI: 1700649043; TIN: 320602652) and primary practice location at 34238-2806. Kalnoky is affiliated with the Privia Quality Network Central Florida, LLC (ACO ID: A4947), participating under the MSSP model.

Kalnoky's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 632 traditional Medicare patients, billed 4,885 HCPCS/CPT codes, and received $270,751 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 3,149 prescription claims across 459 beneficiaries totaling $198,433 in drug costs, led by Ozempic (Semaglutide). DME data shows 253 claims. Open Payments data shows 20 records totaling $410. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $3,107 to $270,751. Similarly, Part D prescription costs have risen steadily, from $87,347 to $198,433. For DME billing, reported payments moved sharply higher in recent years, from $2,602 to $997,414.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	74	89	$3,107
2016	799	890	$46,272
2017	848	1,181	$71,255
2018	397	946	$71,249
2019	379	2,000	$132,990
2020	399	3,163	$145,403
2021	414	3,302	$174,054
2022	475	3,341	$191,289
2023	531	4,383	$282,948
2024	632	4,885	$270,751

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	317	1,734	$87,347
2016	403	758	$24,007
2017	352	959	$24,278
2018	230	1,481	$90,660
2019	299	2,845	$159,170
2020	359	3,695	$253,449
2021	394	3,463	$284,467
2022	371	2,610	$264,588
2023	324	2,290	$244,503
2024	459	3,149	$198,433

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	47	$1,735
2016	N/R	46	$1,246
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	20	$240
2021	N/R	64	$1,320
2022	N/R	118	$3,496
2023	N/R	89	$2,964
2024	239	253	$2,090,588

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	318	318	$126
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	416	827	$83
99497	Advance care planning, first 30 minutes	306	306	$79
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	270	420	$57
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	443	851	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	20	616	$18,904
Eliquis	Apixaban	16	900	$16,959
Mounjaro	Tirzepatide	14	392	$14,637
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	79	2,161	$2,652
Rosuvastatin Calcium	Rosuvastatin Calcium	174	15,534	$2,033

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4353	Intermittent urinary catheter, with insertion supplies	N	119	119	$1,099,467
A6197	Alginate or other fiber gelling dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., each dressing	N	120	120	$990,913
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	N/R	14	$209

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	20	$410	Novo Nordisk Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Achilles Kalnoky, M.D.?

Tedicare shows public-source Medicare data for Achilles Kalnoky, M.D. (NPI 1245460690), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Achilles Kalnoky, M.D. have ACO affiliation data?

Achilles Kalnoky, M.D. is shown with ACO affiliation data for Privia Quality Network Central Florida, LLC (MSSP, ACO ID A4947).

What billing organization is linked to Achilles Kalnoky, M.D.?

Achilles Kalnoky, M.D. is linked to HEALTH FIRST PRIVIA MEDICAL GROUP (billing NPI 1700649043) in the available physician profile data.

Does Achilles Kalnoky, M.D. have Open Payments data?

Achilles Kalnoky, M.D. has 20 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.